This letter is in response to the letter by Dr. Therese J. Bocklage et al. [1] . Our original intention was to indicate the fact that our publication was the first series of thyroid cases (albeit small) under the following title: Mammary Analog Secretory Carcinoma (MASC) involving the thyroid gland: a report of the first 3 cases [2] . We agree that the chronological events presented by Bocklage et al. are correct and the words ''the first'' should be removed for clarity [1] .
Our paper was submitted and was received by Head and Neck Pathology on May 11, 2016. Our revision was submitted for final review on June 13, 2016. Our paper was accepted for publication on June 24, 2016 and was available for as electronic publication on July 11, 2016 [2] . Of note, in our publication, we did include the first published case of thyroid involvement by a carcinoma with mammary analog secretory carcinoma morphology [3] .
The case by Reynolds et al. became available on line as electronic publication ahead of print in Head and Neck Pathology on April 13, 2016 [4] ; this single case was included in our discussion and in our references [2] . On June 10, 2016, the publication by Dogan et al. [5] became available on line as electronic publication ahead of print. This latter publication was not included in our review of literature. We echo the sentiments of the authors in that these cases are important to identify since they would (as expected) not appear to respond to radioactive iodine. We would also add given the limited case number and followup, there is still concern that at least some of the cases reported to date may be metastases or extension from 
